Your browser doesn't support javascript.
loading
Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study.
Kido, Koichi; Hatakeyama, Shingo; Numakura, Kazuyuki; Tanaka, Toshikazu; Oikawa, Masaaki; Noro, Daisuke; Hosogoe, Shogo; Narita, Shintaro; Inoue, Takamitsu; Yoneyama, Takahiro; Ito, Hiroyuki; Nishimura, Shoji; Hashimoto, Yasuhiro; Kawaguchi, Toshiaki; Habuchi, Tomonori; Ohyama, Chikara.
Affiliation
  • Kido K; Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Hatakeyama S; Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. shingoh@hirosaki-u.ac.jp.
  • Numakura K; Department of Advanced Blood Purification Therapy, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. shingoh@hirosaki-u.ac.jp.
  • Tanaka T; Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.
  • Oikawa M; Department of Urology, Aomori Prefectural Central Hospital, Aomori, Japan.
  • Noro D; Department of Urology, Hakodate Municipal Hospital, Hakodate, Japan.
  • Hosogoe S; Department of Urology, Mutsu General Hospital, Mutsu, Japan.
  • Narita S; Department of Urology, Aomori City Hospital, Aomori, Japan.
  • Inoue T; Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.
  • Yoneyama T; Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.
  • Ito H; Department of Advanced Transplant Regenerative Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Nishimura S; Department of Urology, Aomori Rosai Hospital, Hachinohe, Japan.
  • Hashimoto Y; Department of Urology, Hakodate Municipal Hospital, Hakodate, Japan.
  • Kawaguchi T; Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Habuchi T; Department of Urology, Aomori Prefectural Central Hospital, Aomori, Japan.
  • Ohyama C; Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.
Int J Clin Oncol ; 26(1): 154-162, 2021 Jan.
Article in En | MEDLINE | ID: mdl-33067647
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Antineoplastic Agents, Immunological / Kidney Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Int J Clin Oncol Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Antineoplastic Agents, Immunological / Kidney Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Int J Clin Oncol Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Country of publication: